Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Buy

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Buy

A

Axogen, Inc. Common Stock (AXGN)

Electromedical & Electrotherapeutic Apparatus

https://www.axogeninc.com

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

13631 PROGRESS BLVD., SUITE 400
ALACHUA, FL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/17/1986

Market Cap

511,562,343

Shares Outstanding

43,040,000

Weighted SO

43,043,606

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

ANIK --.--%

OFIX --.--%

SRDX --.--%

FNA --.--%

AORT --.--%

LUNG --.--%

ELMD --.--%

RXST --.--%

TMCI --.--%

Beta

1.1040

Last Div

0.0000

Range

3.45-11.7273

Chg

0.6850

Avg Vol

421000

Mkt Cap

511562343

Exch

NASDAQ

Country

US

Phone

386 462 6800

DCF Diff

1.4496

DCF

11.6596

Div Yield

0.0000

P/S

2.9488

EV Multiple

-111.1917

P/FV

5.3473

Div Yield %

0.0000

P/E

-30.9387

PEG

-2.9326

Payout

0.0000

Current Ratio

3.5132

Quick Ratio

2.3168

Cash Ratio

1.0758

DSO

52.9186

DIO

265.4175

Op Cycle

318.3361

DPO

205.2474

CCC

113.0888

Gross Margin

0.7779

Op Margin

-0.0704

Pretax Margin

-0.0953

Net Margin

-0.0953

Eff Tax Rate

-0.1419

ROA

-0.0875

ROE

-0.1730

ROCE

-0.0738

NI/EBT

1.0000

EBT/EBIT

1.3548

EBIT/Rev

-0.0704

Debt Ratio

0.2583

D/E

0.5100

LT Debt/Cap

0.3296

Total Debt/Cap

0.3377

Int Coverage

-4.2742

CF/Debt

-0.1370

Equity Multi

1.9745

Rec Turnover

6.8974

Pay Turnover

1.7783

Inv Turnover

1.3752

FA Turnover

1.7058

Asset Turnover

0.9182

OCF/Share

-0.1530

FCF/Share

-0.3418

Cash/Share

0.6207

OCF/Sales

-0.0385

FCF/OCF

2.2348

CF Coverage

-0.1370

ST Coverage

-3.8184

CapEx Coverage

-0.8098

Div&CapEx Cov

-0.8098

P/BV

5.3473

P/B

5.3473

P/S

2.9488

P/E

-30.9387

P/FCF

-34.2365

P/OCF

-76.5277

P/CF

-76.5277

PEG

-2.9326

P/S

2.9488

EV Multiple

-111.1917

P/FV

5.3473

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 18, 17:00 Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap GlobeNewswire Inc. Jan 04, 16:45 Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023 GlobeNewswire Inc. Jan 04, 16:45 Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023 GlobeNewswire Inc. Jan 04, 16:40 Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025 GlobeNewswire Inc. Jan 04, 16:35 Axogen Announces Promotions on Research and Development Team GlobeNewswire Inc. Dec 26, 16:15 Axogen, Inc. Appoints Kathy Weiler to its Board of Directors GlobeNewswire Inc. Dec 26, 16:15 Axogen, Inc. Appoints Kathy Weiler to its Board of Directors GlobeNewswire Inc. Dec 01, 17:00 Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
1.00 01/27/2010 12/22/2009 01/29/2010 02/12/2010
0.06 02/23/2005 11/30/-0001 11/30/-0001 11/30/-0001
0.04 07/10/1992 11/30/-0001 11/30/-0001 11/30/-0001
a